An interventional study of Reflexologic Magnetic Insole Group and Orthopedic Insole Group in Primary Dysmenorrhea, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 81 studies in Dysmenorrhea with a site in Turkey — 19 open to participants now, 23 under way, none of them phase 3. Dysmenorrhea · Turkey.
Among the 81 studies in Dysmenorrhea with a site in Turkey, this one is the 36th largest by enrollment of the 72 interventional ones that give a count, is one of 7 that started in 2022, is one of 70 with no phase, and was the 39th registered.
432 studies on the registry are indexed under Dysmenorrhea; 108 are open to participants now.
Browse Dysmenorrhea studies →19 of the 81 studies in Dysmenorrhea with a site in Turkey are open now. Recruiting first, the newest first:
Tokat Gaziosmanpasa University · Sites in Turkey
Ages 18+ · Women only · Healthy volunteers
Istanbul Medipol University Hospital · Sites in Turkey
Ages 18–30 · Women only
Ankara University · Sites in Turkey
Ages 18–25 · Women only
Nigde Omer Halisdemir University · Sites in Turkey
Ages 18–30 · Women only · Healthy volunteers
Acibadem University · Sites in Turkey
Ages 10–19 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 59 Dysmenorrhea studies recruiting now, 7 (12%) set no upper age limit and 51 (86%) stop at 75 or younger; 12 take children under 18; 20 take healthy volunteers.
This study: 18 Years to 30 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
81 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 7 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is close to the median of 62 across 364 interventional studies indexed under Dysmenorrhea.
Median enrollment 60 across the 72 interventional studies, 60 across the 9 observational. Of the 52 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 81 has an industry lead sponsor. The 10 most frequent:
Istanbul Medipol University Hospital is the lead sponsor of 368 studies on the registry; 48 are open to participants now.
Istanbul Medipol University Hospital has 3 studies filed under Dysmenorrhea — fewer than ten, so there is no comparison to draw.
2 of the studies in Dysmenorrhea with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06398990Acibadem UniversityThe Effect of Cognitive Exercise Therapy Approach and Yoga in Adolescents With Dysmenorrhoea | 2026-12 |
| NCT07409337Nigde Omer Halisdemir UniversitySelf-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms | 2026-12-15 |
Add all 2 to your calendar (.ics) → With an account.
Among the 81 studies in Dysmenorrhea with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In the study, easy-to-access and easy-to-use reflexologic magnetic insoles were used in women with primary dysmenorrhea who did not want to receive medical treatment.
Sixty women diagnosed with primary dysmenorrhea following examination by a gynecologist were included in the study. The participants were randomly assigned to two groups. Participants in the Reflexologic Magnetic Insoles Sham Group used insoles.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants placed the insoles inside their shoes and used them for at least 7 hours a day, every day, for 12 weeks.
Device: Reflexologic Magnetic Insole Group
Participants placed the insoles inside their shoes and used them for at least 7 hours a day, every day, for 12 weeks.
Device: Orthopedic Insole Group
Reflexologic magnetic insoles were used for at least 7 hours a day, every day, for 12 weeks by participants diagnosed with primary dysmenorrhea. The effectiveness of the insoles was then compared.
Orthopedic insoles (sham) were used for at least 7 hours a day, every day, for 12 weeks by participants diagnosed with primary dysmenorrhea. The effectiveness of the insoles was then compared.
McGill Pain Questionnaire-Short Form Total Score
It evaluates the sensory dimension of pain and the affective dimension of pain. Affective and sensory dimension scores of pain are measured with a Likert-type scale (0-No pain, 3-Severe Pain). The total pain dimension subparametric is the sum of the sensory dimension and the affective dimension of the pain. Total pain intensity is measured with a 6-point Likert-type scale (0-No pain, 5-Unbearable Pain). A high score indicates a high level of pain.
Time frame: 12 weeks
Menstruation Attitude Questionnaire
Valuated subdimensions include menstruation as a deliberating event, menstruating as a bothersome event, menstruation as a natural event, anticipation and prediction of the onset of menstruation, and denial of any effects of menstruation. The scale is evaluated with a 5-point Likert-type." A high mean score indicates a "positive" attitude toward menstruation.
Time frame: 12 weeks
Visual Analogue Scale (VAS)
The Visual Analogue Scale (VAS) is used to convert non-numerical values to digital. The value 0 means I have no pain, 10 means I have unbearable pain. The person marks his pain on this ruler. It measures the intensity of the pain.
Time frame: 12 weeks
Menstruation Symptom Questionnaire
It contains 24 items. It is a 5-point Likert type scale. Participants are asked to evaluate the symptoms that occur during menstruation as a-never (1), b-rarely (2), c-sometimes (3), d-often (4) and e-always (5). The overall score of the scale is calculated by taking the average of the total score obtained from the scale items. A higher score indicates that the symptoms are experienced more clearly.
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2022 to primary completion in Aug 2024, 25 months.
Of 179 non-industry interventional studies with no phase under Dysmenorrhea, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 16. This study's 25 months is above that.
Counting every sponsor, half of 189 studies reached it within 8 months; a quarter within 3 and three quarters within 17.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: start May 2024 → Jun 2022 and completion Sep 2024 → Sep 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Medipol University Hospital →